Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | LDHB | P07195 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6866550 | 0.80 | ALDH1A1 (0.35) | ALDH1A1TSHRFGFR4ALOX15HSD17B10 | |
| Bicarbonate SCHEMBL27619866 | 0.76 | TSHR (0.40) | ALDH1A1TSHRFGFR4ALOX15HSD17B10 | |
| SCHEMBL464885 | 0.75 | — | — | |
| SCHEMBL12657792 | 0.74 | — | — | |
| Formaldehyde SCHEMBL29225333 | 0.73 | — | — | |
| Ethylene SCHEMBL27770741 | 0.73 | — | — | |
| SCHEMBL27797811 | 0.73 | — | — | |
| Acrylic Acid SCHEMBL6314191 | 0.72 | LMNA (0.53) | ALDH1A1TSHRFGFR4ALOX15HSD17B10 | |
| Acetic Acid SCHEMBL11810222 | 0.72 | CRBN (0.43) | ALDH1A1TSHRFGFR4ALOX15HSD17B10 | |
| Methacrylic Acid SCHEMBL6314204 | 0.71 | TDP1 (0.42) | ALDH1A1TSHRFGFR4ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021143724-A1 | 4-UREIDO-5-CARBOXYL-IMIDAZOLE-AMIDE HYDROLASE AND USE THEREOF | 天津大学 | 2021-07-22 | — | — | WO | disclosed |
| US-20190209493-A1 | NOVEL APPLICATIONS OF SPERMINE AND DERIVATIVES THEREOF | GENEHEAL BIOTECHNOLOGY CO., LTD. (CN) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190209493-A1 | NOVEL APPLICATIONS OF SPERMINE AND DERIVATIVES THEREOF | ADSL, SMS, SRM | ALDH1A1 1359/4885TSHR 2796/4885FGFR4 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.